ORAL Surveillance Author Interview – Roy Fleischmann

Medicine via myPod

English - February 09, 2022 13:33 - 37 minutes
Music podcasting Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: #326 - Christine Olivia - Cacao Queen Shares The Benefits Of Plant Medicines Including Ceremonial Cacao

Next Episode: 162: Unlock the Secrets of High Achievement and Success with Ruth Gotian

Cytokine Signalling Forum

Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Roy Fleishmann discusses the ORAL Surveillance study into CV and cancer risks with tofacitinib in patients with RA.

https://www.listennotes.com/e/58822fad4d1a4c47ac70e2e1f18d048e/